Benchmark initiated coverage of Abbott (ABT) with a Buy rating and $145 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Looking for Exposure to UnitedHealth Stock (UNH)? Here’s How to Buy Without the Risk
- Abbott added to US Conviction List at Goldman Sachs
- DexCom assumed with Perform from Outperform at Oppenheimer
- Medtronic’s MiniMed 780G System cleared by FDA for Type 1 and 2 diabetes
- Abbott’s Navitor TAVI system receives CE Mark in Europe